GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OSE Immunotherapeutics SA (XPAR:OSE) » Definitions » Price-to-Funds-From-Operations

OSE Immunotherapeutics (XPAR:OSE) Price-to-Funds-From-Operations : (As of Jun. 06, 2024)


View and export this data going back to 2015. Start your Free Trial

What is OSE Immunotherapeutics Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


OSE Immunotherapeutics (XPAR:OSE) Business Description

Traded in Other Exchanges
Address
22, Boulevard Benoni Goullin, Nantes, FRA, 44200
OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.